Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (51-60 of 165) with videos related to

Pageof 17
Sort By:
Oncogenesis|June 30, 2018
Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignanciesOlga Ostrovsky, Ania Hava Grushchenko-Polaq, Katia Beider, et al.
Cells|October 23, 2021
The HPSE Gene Insulator-A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host DiseaseOlga Ostrovsky, Polina Baryakh, Yan Morgulis, et al.
International Journal of Hematology|July 2, 2021
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantationIvetta Danylesko, Rina Sareli, Nira Varda-Bloom, et al.
Bone Marrow Transplantation|April 24, 2024
Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantationYana Davidov, Noga Shem-Tov, Ronit Yerushalmi, et al.
Leukemia Research|August 19, 2007
A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD)Maya Koren-Michowitz, Avichai Shimoni, Asaf Vivante, et al.
Cytokine|December 16, 2011
Treatment with interferon alpha prior to discontinuation of imatinib in patients with chronic myeloid leukemiaIzhar Hardan, Anfisa Stanevsky, Yuliya Volchek, et al.
European Journal of Haematology|July 24, 2019
Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantationRoni Shouval, Elizaveta Kouniavski, Joshua Fein, et al.
Cancer|November 13, 2014
Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemiaAvichai Shimoni, Yulia Volchek, Maya Koren-Michowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignanciesRaanan Berger, Rinat Rotem-Yehudar, Gideon Slama, et al.
Annals of Hematology|October 14, 2014
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantationMaya Koren-Michowitz, Hannah Maayan, Arie Apel, et al.
Pageof 17

Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
Oncogenesis|June 30, 2018
Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignanciesOlga Ostrovsky, Ania Hava Grushchenko-Polaq, Katia Beider, et al.
Cells|October 23, 2021
The HPSE Gene Insulator-A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host DiseaseOlga Ostrovsky, Polina Baryakh, Yan Morgulis, et al.
International Journal of Hematology|July 2, 2021
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantationIvetta Danylesko, Rina Sareli, Nira Varda-Bloom, et al.
Bone Marrow Transplantation|April 24, 2024
Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantationYana Davidov, Noga Shem-Tov, Ronit Yerushalmi, et al.
Leukemia Research|August 19, 2007
A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD)Maya Koren-Michowitz, Avichai Shimoni, Asaf Vivante, et al.
Cytokine|December 16, 2011
Treatment with interferon alpha prior to discontinuation of imatinib in patients with chronic myeloid leukemiaIzhar Hardan, Anfisa Stanevsky, Yuliya Volchek, et al.
European Journal of Haematology|July 24, 2019
Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantationRoni Shouval, Elizaveta Kouniavski, Joshua Fein, et al.
Cancer|November 13, 2014
Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemiaAvichai Shimoni, Yulia Volchek, Maya Koren-Michowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignanciesRaanan Berger, Rinat Rotem-Yehudar, Gideon Slama, et al.
Annals of Hematology|October 14, 2014
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantationMaya Koren-Michowitz, Hannah Maayan, Arie Apel, et al.
Pageof 17